CYP19A1 and breast cancer: Given this background, breast cancer survivors may have an even greater overall risk of fractures due to the bone loss induced by adjuvant hormonal therapy (aromatase inhibitors), toxicity of the chemotherapies themselves, and/or greater use of sleep aids to cope with sleep problems.